UNSPSC 51332703: Clozapine

This classification denotes a 5-ht3 receptor antagonist and antipsychotic agent with the molecular formula C18H19ClN4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier J60AR2IKIC, chemically known as 8-chloro-11-(4-methyl-1-piperazinyl)-5h-dibenzo(b,e)(1,4)diazepine but generally known as clozapine, which bears US NIH Compound Identifier 2818. European Medicines Agency schedules Clozapine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06787MIG.

UNSPSC 51332703 Clozapine is a Commodity code that represents pharmaceutical procurement, though the recent state and local solicitation record shows a mismatch between the code's nominal scope and actual buying activity. Seminole County, Florida posted an IFB in June 2026 tagged to this code, but the solicitation sought naloxone and safe drug deactivation systems—not clozapine. The county procurement does reflect state and local government spending on emergency medical and harm-reduction pharmaceuticals and devices, with vendors required to meet standard compliance obligations including drug-free workplace certification, E-Verify authorization, workers' compensation and general liability insurance, and potential FEMA-driven federal regulatory requirements such as Clean Air Act and Federal Water Pollution Control Act adherence. The Seminole County opportunity carried a two-year initial term with a one-year renewal option and included a three-month probationary termination right.

The geographic and opportunity data are limited. The only recent state and local posting under this code is the Seminole County, Florida IFB 60459723LAS, due July 26, 2023 (note: the posted date of June 30, 2026 appears inconsistent with the due date and warrant verification before pursuit). The county sought 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, and all shipping costs to be included in bids. No other jurisdictions or states show recent activity under this code, and the single opportunity's mismatch with the code's pharmaceutical label suggests either a tagging error in the state procurement system or minimal clozapine-specific buying at the state and local level.